Want to buy for someone else? You can purchase a token at check out.
Overview
Allergic rhinitis (AR) affects an estimated 50 million people in the United States (> 16% of the population annually) and costs more than 18 billion each year. Allergic rhinitis is the 6th leading cause of chronic illness in the United States. The prevalence of allergic rhinitis in children is increasing and is a common cause of nasal congestion in children. The burden of allergic rhinitis is substantial and a significant cause of widespread morbidity, medical treatment costs, decreased quality of life (QOL), reduced work productivity, and lost school days. Surveys have found that AR is an independent risk factor for the development of asthma. In the United States, 38% of patients with AR have asthma, and up to 78% of asthma patients have AR. This course will update healthcare professionals’ knowledge of the diagnosis and treatment of allergic rhinitis and its implications for related comorbid allergic airway disease.
Goals and Learning Outcomes
- Explain the difference between early- and late-phase allergic responses.
- List five categories of questions for obtaining a patient history relevant to allergic rhinitis.
- Discuss the first-line treatment regimen for allergic rhinitis.
- Discuss how allergic rhinitis affects the quality of life of the patients affected.
Course Details
Course Originally Released on : 4/30/2002
CE300-60
Course Author
MSN, RN, APNP, AE-C
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.